Vertical realignment, GenAI initiatives, and strong deal wins drive momentum into FY26
Digital transformation specialist Happiest Minds Technologies reported a robust performance for Q4 FY25, registering revenues of ₹545 Crores—a 31% year-on-year increase in constant currency—and 1.1% sequential growth. For the full fiscal, the company posted revenues of ₹2,162.2 Crores and EBITDA of ₹462.2 Crores, maintaining a healthy 21.4% operating margin.
Ashok Soota, Chairman & Chief Mentor, highlighted the company’s resilience: “Despite projected slowdowns in major markets, we see no recessionary impact. Demand remains strong, and our strategic changes are already showing results.”
Co-Chairman & CEO Joseph Anantharaju credited the shift to a verticalized business model and focused GenAI initiatives for the performance surge. “Healthcare and BFSI saw strong traction, with the Healthcare vertical securing $20 million in new deals across four customers,” he said. “Our GenAI business unit and newly created ‘Next-Name Hunting’ team are building a robust pipeline.”
“The ten strategic transformational changes we rolled out are shaping Happiest Minds’ future.”
— Ashok Soota, Chairman & Chief Mentor, Happiest Minds Technologies
Quarter Highlights – Q4 FY25:
- Constant currency revenue up 1.1% QoQ, 27.9% YoY
- Revenue in USD: $63 million, up 25.6% YoY
- EBITDA: ₹109.8 Cr (19.3% of total income), impacted by a one-time bad debt
- Adjusted PAT: ₹56.7 Cr, Adjusted EPS: ₹3.76
- Total clients: 281, with 14 new additions
- Employee strength: 6,632, attrition at 16.6%
Strategic Wins:
- Generative AI-powered user experience solution for a global research agency
- Connected product engineering for a US-based industrial firm
- Cybersecurity and risk consulting for Middle Eastern clients in e-commerce and banking sectors
Accolades:
- Best DevOps Framework for Scalability and Security at India DevOps Show 2025
- Ranked 2nd in “IT Services” at ESC Export Excellence Awards
- Named an ‘Inspiring Firm in AI & Analytics’ by 3AI ACME Awards
Venkatraman Narayanan, MD & CFO, noted, “With 26% annual growth in constant currency and industry-leading margins, we’ve successfully balanced investment in future growth areas like GenAI while maintaining strong profitability.”
The Board has recommended a final dividend of ₹3.5 per equity share for FY25, subject to shareholder approval.